1959
DOI: 10.1016/s0007-0971(59)80004-8
|View full text |Cite
|
Sign up to set email alerts
|

The bronchial spread of lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
16
0
3

Year Published

1973
1973
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 46 publications
(19 citation statements)
references
References 12 publications
0
16
0
3
Order By: Relevance
“…20 Many but not all studies of positive margins of surgically treated lung cancers have shown adverse impact by residual disease. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16] Microscopic residual tumor at the bronchial resection margin has then been divided into different patterns. Cotton 1 first divided microscopic residual disease into mucosal tumor (spreading from a mucosal lesion), and extramucosal microscopic residual disease (tumor involving peribronchial soft tissues or tumor within lymphatics).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…20 Many but not all studies of positive margins of surgically treated lung cancers have shown adverse impact by residual disease. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16] Microscopic residual tumor at the bronchial resection margin has then been divided into different patterns. Cotton 1 first divided microscopic residual disease into mucosal tumor (spreading from a mucosal lesion), and extramucosal microscopic residual disease (tumor involving peribronchial soft tissues or tumor within lymphatics).…”
Section: Discussionmentioning
confidence: 99%
“…Cotton 1 first divided microscopic residual disease into mucosal tumor (spreading from a mucosal lesion), and extramucosal microscopic residual disease (tumor involving peribronchial soft tissues or tumor within lymphatics). 1 Extramucosal tumor had a worse prognosis. Soorae divided microscopic residual disease into four patterns: direct submucosal extension of invasive cancer, carcinoma in situ, tumor present in lymphatics at the margin, and parabronchial invasive tumor.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…6,7 While the mucosal tumor usually presents as exophytic mass within the lumen of a bronchus, the endoscopic evidences of submucosal and peribronchial tumors may be more subtle in presentation, as: erythema, loss of normal bronchial markings, bronchial narrowing, thickening of the mucosal stripes, or extrinsic compression of the bronchus. 4 Although the diagnostic yield of bronchoscopic forceps biopsy is very high for exophytic masses, submucosal or peribronchial disease is more difficult to sample through the standard forceps biopsy.…”
Section: Discussionmentioning
confidence: 99%